Therefore, this report represents the first documented prolonged water fast for a patient with morbid obesity (BMI 40) since 1973, when Angus Barbieri lost 276 pounds (82 kg) over 382 days [10]
Abstract Background: Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease
Regarding cardiovascular outcomes, semaglutide proved equally effective for both genders, improving the KCCQ-CSS score by 7.6 points in women and 7.5 points in men
Another benefit of semaglutide: studies have found that it reduces the risk of heart attack, heart disease, and stroke in those with a history of cardiovascular disease
Benefits from this cutting-edge medication include: Most patients experience a significant reduction in body weight, with studies showing an average weight loss of 10-15% of body mass
Careful monitoring may be required to avoid this complication